Compare SCLX & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | TPCS |
|---|---|---|
| Founded | 2011 | 1956 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 39.4M |
| IPO Year | N/A | 2008 |
| Metric | SCLX | TPCS |
|---|---|---|
| Price | $5.69 | $3.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.6K | 23.6K |
| Earning Date | 04-10-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.20 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,031,000.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $4.20 | $2.88 |
| 52 Week High | $34.27 | $6.25 |
| Indicator | SCLX | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 32.75 |
| Support Level | $4.20 | $3.40 |
| Resistance Level | $7.77 | $4.01 |
| Average True Range (ATR) | 0.98 | 0.15 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 1.38 | 10.00 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.